Kansas Gov. Sam Brownback is expected to veto expansion of Medicaid in Kansas. » Read More
By: Bertha Coombs
The GOP health-care bill's defeat removes uncertainty for insurers as they prep 2018 rates, but unresolved legal issues remain. » Read More
House Republican leaders last week canceled a planned vote on their Obamacare replacement because of opposition by members of the party. » Read More
Almost 200,000 people have fatally overdosed on opioids in the past 15 years, with more than 30,000 people dying in 2015 alone. » Read More
As much as 55 percent of the country will have two or fewer Obamacare insurers to choose from.
Officials have launched an investigation to see if providers may be steering patients into Obamacare plans.
CNBC and NBC NY found thousands of FDA safety reports where deaths were classified as less serious injuries and equipment malfunctions.
Health savings accounts let you save for health-care expenses and retirement if you use them effectively. Are you spending or saving?
The inquiry relates to people who are eligible for Medicare and Medicaid.
People have been diagnosed with a rare paralyzing condition caused by Zika virus infection, NBC News reports.
A dramatic drop in the uninsured rate nationally has not been matched in states that did not expand Medicaid.
U.S. government warnings that a quarter of Puerto Ricans could be infected with Zika are overblown, Clarisa Jimenez said.
The insurer had been asking for average rate hikes of more than 17% before its decision to exit.
Companies are also paying higher premiums, and having workers pay more in premiums, executives said.
Aetna's decision to exit many Obamacare markets echoes similar moves by two other big insurers.
The hunt for yield has increased valuations for pharma stocks above their biotech counterparts, a rare feat that may present a buying opportunity.
Aetna says it will offer individual Affordable Care Act exchange plans in just four states, down from 15 this year, to reduce its losses.
This pediatrician can't believe that Congress would take a seven-week vacation at the height of mosquito season without approving Zika funding first.
Aetna dropping Obamacare is another bad omen for the program, says consultant Robert Laszewski. But we can still make it work.
Shares of Valeant Pharmaceuticals rose more than 6 percent after a Mizuho Securities analyst who had been bearish on the stock upgraded it.
CXRX shares plunged more than 27 percent after it posted quarterly earnings that missed estimates and replaced their CFO.
You'll be paying even more for health insurance at work in 2017. Get the lowdown on a plan that can help you save.
Valeant Pharmaceuticals shares fell more than 9 percent in pre-market trading after The Wall Street Journal reported the company is under federal investigation.
Endo International shares surged after it posted second-quarter earnings that exceeded analysts expectations and appointed new management.
Get the best of CNBC in your inbox